RPSG Ventures approves Clarionix acquisition and hospital merger scheme

Listed Co AcquisitionNclt Scheme FiledStrategic Transactions View source PDF Explain this filing

RPSGVENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹889.75

prior close

₹872.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-2.9% vs market

Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, median of 8sector-0.5%-2.6% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.6 pts less than its Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.3

15m

-1.1

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-0.3-2.9-0.5-2.6

Next day

-5.1+0.8-5.9-0.8-4.4

-5.5+0.9-6.4-1.1-4.4

-6.4+1.8-8.2-0.4-6.1

-6.8+1.5-8.2+2.1-8.9

-2.1+1.7-3.7+2.9-5.0

+2.9-1.1+4.0-1.5+4.4

15d

+2.8+1.0+1.8+4.5-1.7

+5.7+0.4+5.4+4.8+0.9

-4.7+6.4-11.0-1.1-3.6

-6.6+5.5-12.1+0.9-7.6

UpDownMarket · Nifty Microcap 250Sector · Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, median of 8Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPSG Ventures board approved acquiring 100% of Clarionix Healthcare (WOS) for INR 1 lakh, and a composite scheme: Woodlands Multispeciality Hospital (assets INR 458 cr, revenue INR 250 cr) merges into RPSG Ventures, then the hospital undertaking transfers to Clarionix via slump sale for INR 400 crore. Swap ratio: 500 OCRPS per WMHL share. Subject to NCLT and other approvals.

Likely market impact

Restructures healthcare business under WOS; promoter stake rises from 63.51% to 68.91% on full OCRPS conversion. Awaiting NCLT approval.